Skip to main content
SpringerLink
Log in

Phytotherapie bei psychiatrischen Erkrankungen

Herbal medicines for psychiatric disorders

  • Leitthema
  • Published:
Der Nervenarzt Aims and scope Submit manuscript

Zusammenfassung

Hintergrund

Pflanzliche Arzneimittel werden in Deutschland traditionell sehr häufig genutzt. Vor allem in der Selbstmedikation stellen sie eine wichtige Therapieoption dar.

Methodik

Aktuelle systematische Übersichtsarbeiten und Metaanalysen wurden hinsichtlich der Evidenz phytotherapeutischer Arzneimittel bei ausgesuchten psychischen Erkrankungen ausgewertet und zusammengefasst.

Ergebnisse

Abgesehen von Johanniskraut bei Depressionen ist die Evidenzlage für kein Phytopharmakon in der Psychiatrie bisher überzeugend.

Schlussfolgerung

Aufgrund der vielversprechenden Wirkungen und dem niedrigen Nebenwirkungspotenzial in den vorhandenen Studien sind weitere randomisiert kontrollierte Studien (z. B. für Passiflora incarnata, Rhodiola rosea oder Lavendula officinalis) jedoch durchaus indiziert.

Abstract

Background

In Germany herbal medicines are traditionally frequently used. They represent an important therapeutic option, especially in self-medication.

Methods

Current systematic review articles and meta-analyses were evaluated and summarized with respect to the evidence of phytotherapeutic drugs for selected psychiatric indications.

Results

Apart from the use of St. John’s wort for depression, no other herb has so far shown convincing evidence.

Conclusion

Due to the promising effects and the low side effect potential within the existing studies, further randomized controlled trials (e. g. for Passiflora incarnata, Rhodiola rosea and Lavendula officinalis) are definitely indicated.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Adib-Hajbaghery M, Mousavi SN (2017) The effects of chamomile extract on sleep quality among elderly people: a clinical trial. Complement Ther Med 35:109–114

    Article  PubMed  Google Scholar 

  2. Anheyer D, Lauche R, Schumann D et al (2017) Herbal medicines in children with attention deficit hyperactivity disorder (ADHD): a systematic review. Complement Ther Med 30:14–23

    Article  PubMed  Google Scholar 

  3. Apaydin EA, Maher AR, Shanman R et al (2016) A systematic review of St. John’s wort for major depressive disorder. Syst Rev 5:148

    Article  PubMed  PubMed Central  Google Scholar 

  4. Baek JH, Nierenberg AA, Kinrys G (2014) Clinical applications of herbal medicines for anxiety and insomnia; targeting patients with bipolar disorder. Aust N Z J Psychiatry 48:705–715

    Article  PubMed  Google Scholar 

  5. Baric H, Dordevic V, Cerovecki I et al (2018) Complementary and alternative medicine treatments for generalized anxiety disorder: systematic review and Meta-analysis of randomized controlled trials. Adv Ther 35:261–288

    Article  PubMed  Google Scholar 

  6. Bent S, Padula A, Moore D et al (2006) Valerian for sleep: a systematic review and meta-analysis. Am J Med 119:1005–1012

    Article  PubMed  PubMed Central  Google Scholar 

  7. Bündnis Phytotherapie (2018) Positionspapier – Förderung der Phytotherapie in Deutschland. http://www.buendnis-phytotherapie.de/images/Buendnis%20Phytotherapie_PP_Foerderung_Phytotherapie_final.pdf. Zugegriffen: 23. Apr. 2018

    Google Scholar 

  8. Dwyer AV, Whitten DL, Hawrelak JA (2011) Herbal medicines, other than St. John’s Wort, in the treatment of depression: a systematic review. Altern Med Rev 16:40–49

    PubMed  Google Scholar 

  9. European Medicne Agency (2018) Herbal medicinal products. http://www.ema.europa.eu/ema/index.jsp?curl=pages/regulation/general/general_content_000208.jsp. Zugegriffen: 19. Apr. 2018

    Google Scholar 

  10. Fernandez-San-Martin MI, Masa-Font R, Palacios-Soler L et al (2010) Effectiveness of Valerian on insomnia: a meta-analysis of randomized placebo-controlled trials. Sleep Med 11:505–511

    Article  PubMed  Google Scholar 

  11. Hausenblas HA, Saha D, Dubyak PJ et al (2013) Saffron (Crocus sativus L.) and major depressive disorder: a meta-analysis of randomized clinical trials. J Integr Med 11:377–383

    Article  PubMed  PubMed Central  Google Scholar 

  12. Hoyer J, Köllner V (2015) Pflanzliche Mittel bei Angststörungen. Psychother Dialog 16:56–59

    Google Scholar 

  13. Italia S, Brand H, Heinrich J et al (2015) Utilization of complementary and alternative medicine (CAM) among children from a German birth cohort (GINIplus): patterns, costs, and trends of use. BMC Complement Altern Med 15:49

    Article  PubMed  PubMed Central  Google Scholar 

  14. Kean JD, Downey LA, Stough C (2016) A systematic review of the Ayurvedic medicinal herb Bacopa monnieri in child and adolescent populations. Complement Ther Med 29:56–62

    Article  PubMed  Google Scholar 

  15. Kongkeaw C, Dilokthornsakul P, Thanarangsarit P et al (2014) Meta-analysis of randomized controlled trials on cognitive effects of Bacopa monnieri extract. J Ethnopharmacol 151:528–535

    Article  PubMed  Google Scholar 

  16. Leach MJ, Page AT (2015) Herbal medicine for insomnia: a systematic review and meta-analysis. Sleep Med Rev 24:1–12

    Article  PubMed  Google Scholar 

  17. Linde K, Berner MM, Kriston L (2008) St John’s wort for major depression. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD000448.pub3

    Article  PubMed  Google Scholar 

  18. Lopresti AL, Drummond PD (2017) Efficacy of curcumin, and a saffron/curcumin combination for the treatment of major depression: a randomised, double-blind, placebo-controlled study. J Affect Disord 207:188–196

    Article  PubMed  CAS  Google Scholar 

  19. Möller HJ, Volz HP, Dienel A et al (2017) Efficacy of Silexan in subthreshold anxiety: meta-analysis of randomised, placebo-controlled trials. Eur Arch Psychiatry Clin Neurosci. https://doi.org/10.1007/s00406-017-0852-4

    Article  PubMed  Google Scholar 

  20. Nematolahi P, Mehrabani M, Karami-Mohajeri S et al (2018) Effects of Rosmarinus officinalis L. on memory performance, anxiety, depression, and sleep quality in university students: a randomized clinical trial. Complement Ther Clin Pract 30:24–28

    Article  PubMed  Google Scholar 

  21. Ng QX, Koh SSH, Chan HW et al (2017) Clinical use of Curcumin in depression: a meta-analysis. J Am Med Dir Assoc 18:503–508

    Article  PubMed  Google Scholar 

  22. Schnabel K, Binting S, Witt CM et al (2014) Use of complementary and alternative medicine by older adults—a cross-sectional survey. BMC Geriatr 14:38

    Article  PubMed  PubMed Central  Google Scholar 

  23. Tan MS, Yu JT, Tan CC et al (2015) Efficacy and adverse effects of ginkgo biloba for cognitive impairment and dementia: a systematic review and meta-analysis. J Alzheimers Dis 43:589–603

    Article  PubMed  CAS  Google Scholar 

  24. Zick SM, Wright BD, Sen A et al (2011) Preliminary examination of the efficacy and safety of a standardized chamomile extract for chronic primary insomnia: a randomized placebo-controlled pilot study. BMC Complement Altern Med 11:78

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik für Naturheilkunde und Integrative Medizin, Knappschafts-Krankenhaus, Kliniken Essen-Mitte, Am Deimelsberg 34a, 45276, Essen, Deutschland

    D. Anheyer M.A., H. Haller, P. Klose, H. Cramer & G. Dobos

Authors
  1. D. Anheyer M.A.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H. Haller
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. P. Klose
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. H. Cramer
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. G. Dobos
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to D. Anheyer M.A..

Ethics declarations

Interessenkonflikt

D. Anheyer, H. Haller, P. Klose, H. Cramer und G. Dobos geben an, dass kein Interessenkonflikt besteht.

Dieser Beitrag beinhaltet keine von den Autoren durchgeführten Studien an Menschen oder Tieren.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Anheyer, D., Haller, H., Klose, P. et al. Phytotherapie bei psychiatrischen Erkrankungen. Nervenarzt 89, 1009–1013 (2018). https://doi.org/10.1007/s00115-018-0539-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00115-018-0539-8

Schlüsselwörter

Keywords

Search

Navigation